Page 11234..10..»

Category Archives: Global News Feed

ABVC BioPharma Report Updated by Zacks/SCR

Posted: August 31, 2021 at 2:16 am

FREMONT, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Zacks Small Cap Research has issued an update report on the company which may be accessed at:

Original post:
ABVC BioPharma Report Updated by Zacks/SCR

Posted in Global News Feed | Comments Off on ABVC BioPharma Report Updated by Zacks/SCR

Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week

Posted: at 2:16 am

IRVINE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods® diagnostic-guided therapy (DGT), designed to alleviate Irritable Bowel Syndrome (IBS) symptoms. The clinical trial is being conducted by Mayo Clinic, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist hospital and the University of Michigan as primary enrollment centers for this study.

Read the original here:
Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week

Posted in Global News Feed | Comments Off on Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week

XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director

Posted: at 2:16 am

Dr. Ziats Joins Clinical Team Involved in Launch and Management of Clinical Studies Across Multiple Indications Dr. Ziats Joins Clinical Team Involved in Launch and Management of Clinical Studies Across Multiple Indications

Read the original post:
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director

Posted in Global News Feed | Comments Off on XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director

Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Posted: at 2:16 am

NEWTON, Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will present and host one-on-one investor meetings at the upcoming H.C. Wainwright Global Investment Conference September 13-15, 2021.

See more here:
Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Posted in Global News Feed | Comments Off on Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Syneos Health to Present at the 2021 Baird Global Healthcare Conference

Posted: at 2:16 am

MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the 2021 Baird Global Healthcare Conference on September 15, 2021, at 1:25 p.m. ET.

More:
Syneos Health to Present at the 2021 Baird Global Healthcare Conference

Posted in Global News Feed | Comments Off on Syneos Health to Present at the 2021 Baird Global Healthcare Conference

AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19…

Posted: at 2:16 am

SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease diagnostics, announced today that the Company’s manufacturing partner Empowered Diagnostics has filed an amended emergency use authorization (EUA) with the Food and Drug Administration (FDA) for ImmunoPass™, the Company’s rapid test that detects COVID-19 neutralizing antibodies at point-of-care locations.

Here is the original post:
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19...

Posted in Global News Feed | Comments Off on AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19…

22nd Century Group Enters Global Specialty Hops Market

Posted: at 2:16 am

Geographic Expansion into Europe via the Netherlands Geographic Expansion into Europe via the Netherlands

Read the original post:
22nd Century Group Enters Global Specialty Hops Market

Posted in Global News Feed | Comments Off on 22nd Century Group Enters Global Specialty Hops Market

Inventiva announces participation at several investor conferences in September 2021  

Posted: at 2:16 am

Daix (France), August 30, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the Company’s leadership will participate in four upcoming investor conferences in September 2021.

Continue reading here:
Inventiva announces participation at several investor conferences in September 2021  

Posted in Global News Feed | Comments Off on Inventiva announces participation at several investor conferences in September 2021  

Galapagos announces planned retirement of CEO

Posted: at 2:16 am

Excerpt from:
Galapagos announces planned retirement of CEO

Posted in Global News Feed | Comments Off on Galapagos announces planned retirement of CEO

Talis Biomedical Announces CEO Transition

Posted: at 2:16 am

Kim Popovits to serve as interim CEO Kim Popovits to serve as interim CEO

See the original post here:
Talis Biomedical Announces CEO Transition

Posted in Global News Feed | Comments Off on Talis Biomedical Announces CEO Transition

Page 11234..10..»